Search Foundation Fighting Blindness

Displaying 171–180 of 519 news results

Jan 28, 2022

Kriya Therapeutics Licenses Emerging Foundation-Funded Dry AMD Gene Therapy

The Foundation Fighting Blindness is funding Bärb Rohrer, PhD, Medical University of South Carolina, to evaluate safety and efficacy of the gene therapy in a large animal model

Research News
Jan 27, 2022

Diana Davis Spencer Foundation Pledges $5M to Foundation Fighting Blindness for Inherited Retinal Disease Research

Commitment to expand translational research acceleration program and fund career development award.

Foundation News
Jan 19, 2022

ReNeuron Not Continuing Clinical Development of Cell-Based Therapy for RP

Company seeks to out-license its retinal progenitor therapy to a partner

Research News
Jan 19, 2022

Foundation Fighting Blindness Promotes Jason Menzo to President and Chief Operating Officer

Noteworthy Foundation executive increases role within organization.

Foundation News
Jan 18, 2022

Foundation Seeks My Retina Tracker Registry Members with X-Linked Retinitis Pigmentosa for Research Survey

Survey results will inform therapy developers and the agenda for a Patient-Focused Drug Development meeting with Food and Drug Administration representatives.

Research News
Jan 7, 2022

Foundation’s RD Fund Invests in SalioGen Therapeutics, Developer of Novel Gene Coding Technology for Treating Inherited Retinal Diseases

The company is currently developing programs for Stargardt disease (ABCA4), Usher syndrome, RP25 (EYS), and RP1.

Research News
Jan 6, 2022

RD Fund Announces Series B Financing Behind SalioGen Therapeutics

Investment in new portfolio company furthering genetic medicine approaches for individuals affected by retinal degenerative diseases.

In the Press
Jan 5, 2022

SalioGen Therapeutics Closes $115 Million Oversubscribed Series B Financing to Advance Gene Coding™ – A New Category of Genetic Medicine

Series B new investors included Fidelity Management & Research Company LLC, funds and accounts advised by T. Rowe Price Associates, Inc., D1 Capital Partners, SymBiosis, the Cystic Fibrosis Foundation, and the RD Fund (the venture arm of Foundation Fighting Blindness).

In the Press
Jan 5, 2022

Chameleon Biosciences Appoints Silicon Valley Scientist and Entrepreneur, Dr. Thomas Chalberg, to Board Position

Dr. Thomas Chalberg has been recognized by the Foundation Fighting Blindness for his pioneering contributions to research and development.

In the Press
Dec 22, 2021

Organizations collaborate on inherited macular dystrophy program

The Foundation Fighting Blindness and the Nixon Visions Foundation are working together to launch the Nixon Visions Foundation Inherited Macular Dystrophy Program, according to a news release from the organizations.

In the Press